Medipal Holdings
7459.TTSE PRIMEWholesale Trade
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥3.82T | ¥3.67T | ¥3.56T | ¥3.36T | ¥3.29T | ¥3.21T |
| Operating income | ¥53.2bn | ¥55.6bn | ¥47.3bn | ¥49.0bn | ¥45.6bn | ¥38.6bn |
| Ordinary income | ¥75.7bn | ¥65.3bn | ¥64.6bn | ¥65.1bn | ¥62.0bn | ¥53.0bn |
| Net income (owners) | ¥42.5bn | ¥40.3bn | ¥41.5bn | ¥38.8bn | ¥29.4bn | ¥23.9bn |
| Total assets | ¥1.92T | ¥1.82T | ¥1.80T | ¥1.71Tr | ¥1.71T | ¥1.68T |
| Net assets / equity | ¥795.4bn | ¥757.9bn | ¥736.6bn | ¥688.1bn | ¥649.1bn | ¥638.9bn |
| Operating cash flow | ¥46.6bn | ¥60.6bn | ¥61.8bn | ¥16.1bn | ¥61.2bn | ¥34.4bn |
| EPS (basic) | ¥206.67 | ¥193.2 | ¥195.83 | ¥184.82 | ¥140.14 | ¥113.96 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 71 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Animal Health Products And Food Processing Raw Materials Wholesale And Related Business | ¥117.3bn | ¥2.3bn |
| Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Business | ¥1.24T | ¥26.4bn |
| Prescription Pharmaceutical Wholesale Business | ¥2.46T | ¥24.3bn |
| Adjustments & eliminations | — | ¥134m |
| Total | ¥3.82T | ¥53.0bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.